Beta Bionics, based in the US, has announced the first patients have begun home use of dasiglucagon – a stable glucagon analogue – in a clinical trial of the company’s iLet bionic pancreas system for people with Type 1 diabetes. The iLet device features read more »

Abbott and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The companies are taking an innovative approach to connected care by developing tools that combine Abbott’s read more »

A company developing and manufacturing advanced wearable infusion devices has entered into a multi-product development agreement with insulin supplier Sanofi. Developed and manufactured by Enable Injections, the enFuse is an on-body device which allows people to self-administer subcutaneous delivery of high-volume medicines and has read more »

Diabetes UK has called for the Government not to water down plans to introduce mandatory calorie labelling in restaurant, cafe and takeaway chains, which could result in just 0.3% of businesses in England adopting the proposed legislation. The Government’s original plans for calorie read more »

A son has dedicated his university studies to create an acceptable alternative to sugar to help his father and millions of other Mexicans. Javier Larragoiti had just started a degree in chemical engineering in Mexico City when his father was diagnosed with diabetes. read more »

Scotland agrees that the current levels of children’s exposure to junk food advertising is unacceptable, with a survey conducted in June 2019 from Obesity Action Scotland indicating strong support among Scottish adults for a 9pm watershed to be applied to TV, online read more »

The U.S. Food and Drug Administration (FDA) has approved Baqsimi (glucagon) nasal powder 3mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above, as announced by Eli Lilly and Company. Baqsimi is the first and only read more »

Three primary care organisations have been announced as the joint winners of a competition to enable healthcare professionals to offer their patients with Type 2 diabetes access to a behaviour change platform. Ascensia Diabetes Care launched the competition during Diabetes Week to give NHS read more »

Women, their families, friends and healthcare professionals are being asked to take part in a survey on the most important questions to address surrounding healthcare and wellbeing in diabetes and pregnancy. To take part and contribute your questions, CLICK HERE. read more »

A drug used to treat Type 2 diabetes has now been recommended for use on the NHS in certain groups of people with Type 1 diabetes. Following approval for use across Europe, dapagliflozin – the first of its kind in Type 1 diabetes read more »